PackTalk is a blog for the Healthcare Packaging Industry

Sterilization and the FDA Innovation Challenge


Published on November 7, 2019

By now, we are all familiar with the recent discussion around sterilization in the medical device industry. Ethylene oxide or EtO is the most popular sterilization modality in the industry accounting for approximately half of the market. EtO is a colorless gas, and long-term exposure can pose serious health risks. Some US communities located in and around EtO sterilization facilities have become increasingly concerned, ultimately forcing the FDA to take action. 

Good for community members, but potentially problematic for the medical device industry, including hospitals and patients who need the devices impacted by this. To put it bluntly, the FDA is in a bit of a Catch-22 situation with the question becoming: do they allow sterilizers to release harmful gas knowing it may be dangerous, or do they allow a shortage of medical devices that could save lives?

The FDA is currently working with sterilizers to reduce or abate the EtO being released into the atmosphere (99% destruction of EtO is required), while looking into new & innovative ways to sterilize medical devices. EtO has become the most popular form of sterilization for many reasons, with capacity and scalability being a top area of focus. A vaporized hydrogen peroxide sterilizer, for example, is roughly 80 to 100 cubic feet, whereas an EtO sterilizer is about 1500 to 3000 cubic feet.

The good news is that new medical devices can anticipate and prepare for a different sterilization modality. The bad news … that still leaves hundreds of thousands of medical devices on the market today using EtO. The FDA recently issued an innovation challenge to the industry. And while we will do everything we can to support our partners through this, we also look forward to the innovation that will result from this exercise. Any time we are forced to look at our industry through a different lens, resourcefulness and creativity emerge.


 

Jenn Goff
Director, Product Strategy | Oliver Healthcare Packaging

Comments (0)

Related Articles

Human Factors & Usability: An Interview with Expert Shannon Hoste

October 22, 2021

The FDA perspective on human factors and usability in health care was first published on July 18, 2000, with the issuance of US FDA draft document, “Medical Device Use-Safety: Incorporating Human Factors Engineering into Risk Management.” That non-binding...

Learn More

The Quick Pace of Evolution in Healthcare Packaging for Developing Nations

October 22, 2021

Evolution in the healthcare packaging industry is much quicker in developing nations than it is in more developed countries. Continuous improvement is all about minimizing risk while getting products to market quickly is still a top priority. So, what are the...

Learn More

5 Lessons I Learned from My Experience in Healthcare Packaging

October 22, 2021

“Personal development is your springboard to personal excellence. Ongoing, continuous, non-stop personal development literally assures you that there is no limit to what you can accomplish.” – Brian Tracy

In the past 18 years of my career, I have been blessed...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.